---
title: "Pharmacy Compliance"
url: "https://legal.ge/en/service/healthcare-and-pharmaceutical-law-en/pharmacy-compliance-en"
field: "Healthcare & Pharmaceutical Law"
description: "Pharmacy compliance: selective control, series accounting, storage conditions and fines up to 1 000 GEL. Legal.ge."
reviewed: "2026-06-27"
updated: "2026-10-23"
publisher: "legal.ge"
---

# Pharmacy Compliance

> Source: legal.ge, https://legal.ge/en/service/healthcare-and-pharmaceutical-law-en/pharmacy-compliance-en

## Selective Control and the Agency's Supervision

Pharmacy compliance is assessed within the framework of the Law of Georgia on Medicines and Pharmaceutical Activity. Under Article 11, the agency is obliged to conduct risk-assessment-based selective control of the distributors of pharmaceutical products; during the control it is empowered to inspect the distributors' observance of the rules established for traceability and of storage conditions, and in cases provided by legislation — to purchase a product from distributors for laboratory testing.

Article 11-1 refines the control mechanisms: the agency uses laboratory control and the mechanisms of administrative control of the distribution chain, and mainly the administrative one. Laboratory control is applied where there is a high risk of falsification or defect, and in exceptional cases the agency has the discretionary power to apply it without regard to the formal criteria — but not exceeding 10 percent of the inspection frequency within one year. The documentary trace of the distributor stands at the centre of this model: where accounting and notifications are executed in time, administrative control remains a comfortable procedure for the party. For a pharmacy, supervision is thus systemic: the documentary chain and storage conditions are always inspectable, the laboratory — by risk.

The full text is available on legal.ge after signing in: https://legal.ge/en/service/healthcare-and-pharmaceutical-law-en/pharmacy-compliance-en

### What does the agency inspect?

Traceability rules and storage conditions; a sample may be purchased for laboratory study (Article 11).

### What burdens the distributor?

Series accounting, storage means, compliance with the instruction's conditions and immediate reaction to suspect products (Article 17).

### What fine for violating conditions?

500 GEL, upon repetition — 1 000 GEL (Article 37-10).

### Does a pharmacy report side effects?

Yes — information on every case is supplied to the agency (Article 26).